This inventor holds 1 USPTO granted patent. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2023
Title: Innovations of Zhongping Sun in Antibody Discovery
Introduction
Zhongping Sun is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of immunology, particularly in the discovery of specific functional antibodies. His innovative methods have the potential to enhance the efficiency of antibody research and development.
Latest Patents
One of Zhongping Sun's key patents is titled "Method of discovering specific functional antibodies." This invention relates to a novel approach for identifying specific functional antibodies, focusing on the sequence composition and frequency analysis of variable regions of immune host antibodies. Compared to traditional high-throughput antibody sequencing methods, his technique allows for the rapid and accurate acquisition of the full-length sequence of the variable region of antibodies containing candidate CDR3. This method boasts a high success rate for antibody gene pairing and is particularly effective for detecting a limited number of samples, thereby improving the efficiency of obtaining specific functional antibodies.
Career Highlights
Zhongping Sun's career is marked by his dedication to advancing antibody discovery techniques. His innovative approach has garnered attention in the scientific community, showcasing his commitment to enhancing research methodologies in immunology.
Collaborations
Zhongping Sun has collaborated with notable colleagues, including Weizhi Chen and Wang Wang. Their joint efforts have contributed to the development and refinement of antibody discovery methods.
Conclusion
Zhongping Sun's contributions to the field of antibody discovery represent a significant advancement in immunology. His innovative methods are poised to improve the efficiency and accuracy of obtaining specific functional antibodies, paving the way for future research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile